Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience Q2 Operating Loss Widens To SEK 6.8 Mln

Aug 27 (Reuters) - Sprint Bioscience AB SPRINT.ST:

Q2 NET SALES SEK 13.9 (16.7) MILLION

Q2 OPERATING PROFIT SEK -6.8 (-5.6) MILLION

Source text: ID:nMFN6YfFCb

Further company coverage: SPRINT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Sprint Bioscience AB

See all news